[
  {
    "CELL_DIVE_ID": "melanoma_untreated",
    "Patient": 0,
    "Sample_number": 1,
    "Sample_ID": "0_1",
    "MSK_ID_Accession_Num": "S16_27540",
    "MSK_ID_Block_Part": "2_2RS",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Left groin",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "ILI Melphalan, Ipilimumab, Pembrolizumab",
    "Num. IL2 injections": "None"
  },
  {
    "CELL_DIVE_ID": "melanoma_PR",
    "Patient": 0,
    "Sample_number": 2,
    "Sample_ID": "0_2",
    "MSK_ID_Accession_Num": "S16_27540",
    "MSK_ID_Block_Part": "4_2RS",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Left foot",
    "Injection": "IL2",
    "Treatment": "IL2",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "non-CR",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "ILI Melphalan, Ipilimumab, Pembrolizumab",
    "Num. IL2 injections": "4-10",
    "Num. IL2 injections (detailed)": "7",
    "IL2 interval (days)": "15-60",
    "IL2 interval (days) (detailed)": "22"
  },
  {
    "CELL_DIVE_ID": "melanoma_CR",
    "Patient": 0,
    "Sample_number": 3,
    "Sample_ID": "0_3",
    "MSK_ID_Accession_Num": "S16_27540",
    "MSK_ID_Block_Part": "3_3RS",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Left groin",
    "Injection": "IL2",
    "Treatment": "IL2",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "CR",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "ILI Melphalan, Ipilimumab, Pembrolizumab",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "3",
    "IL2 interval (days)": "15-60",
    "IL2 interval (days) (detailed)": "29"
  },
  {
    "CELL_DIVE_ID": "mel_1",
    "Patient": 1,
    "Sample_number": 1,
    "Sample_ID": "1_1",
    "MSK_ID_Accession_Num": "S14_52086",
    "MSK_ID_Block_Part": "1_6U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None"
  },
  {
    "CELL_DIVE_ID": "mel_2",
    "Patient": 1,
    "Sample_number": 2,
    "Sample_ID": "1_2",
    "MSK_ID_Accession_Num": "S16_23128",
    "MSK_ID_Block_Part": "1_3U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "IL2, TVEC",
    "Treatment": "IL2+",
    "IL2 Treated": "+",
    "TVEC Treated": "+",
    "Lesion Response": "non-CR",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": ">10",
    "Num. IL2 injections (detailed)": "12",
    "IL2 interval (days)": ">60",
    "IL2 interval (days) (detailed)": "133",
    "Number_TVEC_injections": 6,
    "TVEC Interval": 28
  },
  {
    "CELL_DIVE_ID": "mel_3",
    "Patient": 1,
    "Sample_number": 3,
    "Sample_ID": "1_3",
    "MSK_ID_Accession_Num": "S16_23128",
    "MSK_ID_Block_Part": "2_2U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "IL2",
    "Treatment": "IL2",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "CR",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "2",
    "IL2 interval (days)": ">60",
    "IL2 interval (days) (detailed)": "287"
  },
  {
    "CELL_DIVE_ID": "mel_4",
    "Patient": 2,
    "Sample_number": 1,
    "Sample_ID": "2_1",
    "MSK_ID_Accession_Num": "S16_13547",
    "MSK_ID_Block_Part": "1_1U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "Ipilimumab, Pembrolizumab",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None"
  },
  {
    "CELL_DIVE_ID": "mel_5",
    "Patient": 2,
    "Sample_number": 2,
    "Sample_ID": "2_2",
    "MSK_ID_Accession_Num": "S16_36769",
    "MSK_ID_Block_Part": "1_1U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "IL2",
    "Treatment": "IL2",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "non-CR",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "Ipilimumab, Pembrolizumab",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "1-3",
    "IL2 interval (days)": "15-60",
    "IL2 interval (days) (detailed)": "22-57"
  },
  {
    "CELL_DIVE_ID": "mel_6",
    "Patient": 2,
    "Sample_number": 3,
    "Sample_ID": "2_3",
    "MSK_ID_Accession_Num": "S16_36769",
    "MSK_ID_Block_Part": "2_1U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "IL2",
    "Treatment": "IL2",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "non-CR",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "Ipilimumab, Pembrolizumab",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "1-3",
    "IL2 interval (days)": "15-60",
    "IL2 interval (days) (detailed)": "22-57"
  },
  {
    "CELL_DIVE_ID": "mel_7",
    "Patient": 2,
    "Sample_number": 4,
    "Sample_ID": "2_4",
    "MSK_ID_Accession_Num": "S16_36769",
    "MSK_ID_Block_Part": "3_2U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "IL2",
    "Treatment": "IL2",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "non-CR",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "Ipilimumab, Pembrolizumab",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "1-3",
    "IL2 interval (days)": "15-60",
    "IL2 interval (days) (detailed)": "22-57"
  },
  {
    "CELL_DIVE_ID": "mel_8",
    "Patient": 3,
    "Sample_number": 1,
    "Sample_ID": "3_1",
    "MSK_ID_Accession_Num": "S15_59057",
    "MSK_ID_Block_Part": "1_6RS",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Left thigh",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "non-ICI",
    "Prior Rx (systemic) (detailed)": "Dabrafenib",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None"
  },
  {
    "CELL_DIVE_ID": "mel_9",
    "Patient": 3,
    "Sample_number": 2,
    "Sample_ID": "3_2",
    "MSK_ID_Accession_Num": "S16_31717",
    "MSK_ID_Block_Part": "1_7SS",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Left thigh",
    "Injection": "IL2, TVEC",
    "Treatment": "IL2+",
    "IL2 Treated": "+",
    "TVEC Treated": "+",
    "Lesion Response": "non-CR",
    "Prior Rx (systemic)": "non-ICI",
    "Prior Rx (systemic) (detailed)": "Dabrafenib",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "2",
    "IL2 interval (days)": ">60",
    "IL2 interval (days) (detailed)": "126",
    "Number_TVEC_injections": 4,
    "TVEC Interval": 42
  },
  {
    "CELL_DIVE_ID": "mel_10",
    "Patient": 3,
    "Sample_number": 3,
    "Sample_ID": "3_3",
    "MSK_ID_Accession_Num": "S16_45933",
    "MSK_ID_Block_Part": "1_2M",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 1,
    "Tumor_subtype": "Melanoma",
    "Site": "Left thigh",
    "Injection": "TVEC",
    "Concurrent_treatment": "Pembrolizumab",
    "Treatment": "TVEC+",
    "IL2 Treated": "-",
    "TVEC Treated": "+",
    "Lesion Response": "non-CR",
    "Prior Rx (systemic)": "non-ICI",
    "Prior Rx (systemic) (detailed)": "Dabrafenib",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None",
    "Number_TVEC_injections": 4,
    "TVEC Interval": 117
  },
  {
    "CELL_DIVE_ID": "mel_11",
    "Patient": 4,
    "Sample_number": 1,
    "Sample_ID": "4_1",
    "MSK_ID_Accession_Num": "S15_13129",
    "MSK_ID_Block_Part": "1_1U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right chest",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None"
  },
  {
    "CELL_DIVE_ID": "mel_12",
    "Patient": 4,
    "Sample_number": 2,
    "Sample_ID": "4_2",
    "MSK_ID_Accession_Num": "S15_13129",
    "MSK_ID_Block_Part": "2_3U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right chest",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None"
  },
  {
    "CELL_DIVE_ID": "mel_13",
    "Patient": 4,
    "Sample_number": 3,
    "Sample_ID": "4_3",
    "MSK_ID_Accession_Num": "S15_70214",
    "MSK_ID_Block_Part": "1_5SS",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right chest",
    "Injection": "IL2",
    "Concurrent_treatment": "Dabrafenib/trametinib",
    "Treatment": "IL2+",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "CR",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "Ipilimumab/nivolumab, Dabrafenib/trametinib, Pembrolizumab",
    "Num. IL2 injections": "4-10",
    "Num. IL2 injections (detailed)": "5",
    "IL2 interval (days)": "<15",
    "IL2 interval (days) (detailed)": "7"
  },
  {
    "CELL_DIVE_ID": "mel_14",
    "Patient": 4,
    "Sample_number": 4,
    "Sample_ID": "4_4",
    "MSK_ID_Accession_Num": "S16_7059",
    "MSK_ID_Block_Part": "1_4SS",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right axilla",
    "Injection": "IL2",
    "Concurrent_treatment": "Dabrafenib/trametinib",
    "Treatment": "IL2+",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "CR",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "Ipilimumab/nivolumab, Dabrafenib/trametinib, Pembrolizumab",
    "Num. IL2 injections": "4-10",
    "Num. IL2 injections (detailed)": "4",
    "IL2 interval (days)": "<15",
    "IL2 interval (days) (detailed)": "14"
  },
  {
    "CELL_DIVE_ID": "mel_15",
    "Patient": 4,
    "Sample_number": 5,
    "Sample_ID": "4_5",
    "MSK_ID_Accession_Num": "S16_33761",
    "MSK_ID_Block_Part": "1_3U",
    "Replicate": "mel_22",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right arm",
    "Injection": "IL2",
    "Concurrent_treatment": "Dabrafenib/trametinib",
    "Treatment": "IL2+",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "CR",
    "Prior Rx (systemic)": "ICI",
    "Prior Rx (systemic) (detailed)": "Ipilimumab/nivolumab, Dabrafenib/trametinib, Pembrolizumab",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "3",
    "IL2 interval (days)": "<15",
    "IL2 interval (days) (detailed)": "14"
  },
  {
    "CELL_DIVE_ID": "mel_16",
    "Patient": 5,
    "Sample_number": 1,
    "Sample_ID": "5_1",
    "MSK_ID_Accession_Num": "S16_6593",
    "MSK_ID_Block_Part": "1_2U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Left ear",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None"
  },
  {
    "CELL_DIVE_ID": "mel_17",
    "Patient": 5,
    "Sample_number": 2,
    "Sample_ID": "5_2",
    "MSK_ID_Accession_Num": "S16_56777",
    "MSK_ID_Block_Part": "1_6S",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Left ear",
    "Injection": "IL2, TVEC",
    "Concurrent_treatment": "Pembrolizumab, Aldara",
    "Treatment": "IL2+",
    "IL2 Treated": "+",
    "TVEC Treated": "+",
    "Lesion Response": "non-CR",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "4-10",
    "Num. IL2 injections (detailed)": "2-4",
    "IL2 interval (days)": ">60",
    "IL2 interval (days) (detailed)": "76-104",
    "Number_TVEC_injections": 1,
    "TVEC Interval": 21
  },
  {
    "CELL_DIVE_ID": "mel_18",
    "Patient": 6,
    "Sample_number": 1,
    "Sample_ID": "6_1",
    "MSK_ID_Accession_Num": "S15_67426",
    "MSK_ID_Block_Part": "1_2U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None"
  },
  {
    "CELL_DIVE_ID": "mel_19",
    "Patient": 6,
    "Sample_number": 2,
    "Sample_ID": "6_2",
    "MSK_ID_Accession_Num": "S16_9581",
    "MSK_ID_Block_Part": "1_1U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "IL2",
    "Treatment": "IL2",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "CR",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "3",
    "IL2 interval (days)": "15-60",
    "IL2 interval (days) (detailed)": "28"
  },
  {
    "CELL_DIVE_ID": "mel_20",
    "Patient": 6,
    "Sample_number": 3,
    "Sample_ID": "6_3",
    "MSK_ID_Accession_Num": "S16_9581",
    "MSK_ID_Block_Part": "2_1U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 2,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "IL2",
    "Treatment": "IL2",
    "IL2 Treated": "+",
    "TVEC Treated": "-",
    "Lesion Response": "CR",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "<4",
    "Num. IL2 injections (detailed)": "3",
    "IL2 interval (days)": "15-60",
    "IL2 interval (days) (detailed)": "28"
  },
  {
    "CELL_DIVE_ID": "mel_21",
    "Patient": 6,
    "Sample_number": 4,
    "Sample_ID": "6_4",
    "MSK_ID_Accession_Num": "S17_22445",
    "MSK_ID_Block_Part": "1_8U",
    "Replicate": "NA",
    "Microscope": "Cytell_2",
    "Slide_holder_position": 1,
    "Staining_batch": 2,
    "Tumor_subtype": "Melanoma",
    "Site": "Right leg",
    "Injection": "UT",
    "Treatment": "UT",
    "IL2 Treated": "-",
    "TVEC Treated": "-",
    "Lesion Response": "UT",
    "Prior Rx (systemic)": "None",
    "Num. IL2 injections": "None",
    "IL2 interval (days)": "None"
  }
]
